Jazz Pharmaceuticals JAZZ Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's cash provided by (used in) financing activity, including discontinued operation?
- Jazz Pharmaceuticals (JAZZ) reported cash provided by (used in) financing activity, including discontinued operation of -$78.5M in Q1 2026.
- How has Jazz Pharmaceuticals's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Jazz Pharmaceuticals's cash provided by (used in) financing activity, including discontinued operation increased by 90.4% year-over-year, from -$813.5M to -$78.5M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- Net cash flow from borrowing, paying back debt, and equity transactions.
- How do you interpret cash provided by (used in) financing activity, including discontinued operation?
- Negative values often indicate debt repayment or share buybacks, while positive values indicate capital raising.
- How does cash provided by (used in) financing activity, including discontinued operation compare across companies?
- Standard cash flow statement category across all industries.